Kingsway Financial Services Inc. — 2021 Form 10-K
Reporting period: Fiscal year ended December 31, 2021; filed February 28, 2022. Although the request references 2021 Q4, this filing reports full-year results, with 2020 as the comparable period. Amounts are U.S. dollars.
Business context
Kingsway is a U.S.-focused holding company operating in Extended Warranty, Leased Real Estate and Kingsway Search Xcelerator. Its businesses include vehicle, home and equipment warranties; long-term leased properties; and outsourced finance and HR consulting. The company acquired Ravix Financial on October 1, 2021, and RoeCo Lafayette on December 30, 2021.
Financial performance and position
| Metric | 2021 | 2020 |
|---|---|---|
| Total revenue | $91.8 million | $61.0 million |
| GAAP operating income (loss) | $3.2 million | ($5.2 million) |
| Loss from continuing operations before tax | ($5.8 million) | ($6.5 million) |
| Income tax benefit | $7.6 million | $1.1 million |
| Net income (loss) | $1.9 million | ($5.4 million) |
| Net income (loss) attributable to common shareholders | ($0.8 million); loss per share $0.04 | ($7.8 million); loss per share $0.35 |
| Cash from (used in) operating activities | ($5.9 million) | $1.7 million |
- Revenue increased 50.5%, principally because PWI, acquired in December 2020, contributed a full year; Ravix contributed $3.5 million after its acquisition. Extended Warranty revenue was $74.9 million versus $47.6 million, while Leased Real Estate revenue remained $13.4 million.
- Segment operating income was $12.6 million for Extended Warranty (up from $6.6 million), $0.9 million for Leased Real Estate (versus a $0.5 million loss), and $0.5 million for Kingsway Search Xcelerator. Extended Warranty results included $2.2 million of PPP loan forgiveness; excluding that, segment operating income was $10.5 million.
- Net income included a $7.6 million tax benefit, including valuation-allowance and unrecognized-tax-benefit effects. The company still reported a loss attributable to common shareholders after noncontrolling interests and preferred dividends.
- Investing cash use was $8.6 million, including $12.2 million spent on the Ravix and RoeCo acquisitions, net of cash acquired; financing cash use was $0.5 million. Cash, cash equivalents and restricted cash declined to $29.9 million from $44.9 million.
- At year-end, cash and cash equivalents were $12.6 million, restricted cash $17.3 million, and investments $68.4 million. Restricted balances include funds supporting warranty obligations and other collateral requirements; they are not all freely available to the holding company.
- Total assets were $475.6 million and total liabilities $460.9 million. Total shareholders’ equity was $8.3 million; equity attributable to common shareholders was negative $5.7 million.
- Debt principal was approximately $314.1 million: $27.2 million of bank loans, $196.4 million of notes payable and $90.5 million of subordinated debt. The balance-sheet carrying amount was $292.7 million. Much of the notes payable is property-level debt described as nonrecourse. Subordinated debt had $18.7 million of deferred interest accrued; its interest deferral is contractually permitted.
- Holding-company cash liquidity was $2.2 million at year-end, described as about five months of recurring holding-company cash outflows. Management expected existing resources and anticipated operating cash flows to cover working capital and operating expenses for the next 12 months, excluding potential preferred-stock redemption and deferred trust-preferred interest.
Changes, outlook and material risks
- Ravix was acquired for approximately $10.9 million cash consideration, with up to $4.5 million of contingent payments tied to performance. RoeCo was acquired for approximately $2.4 million cash consideration and brought a leased Louisiana medical office property with $13.5 million mortgage principal at acquisition.
- PWI purchase accounting finalized in 2021 reduced acquired deferred service fees by $3.6 million and caused a $1.9 million noncash cumulative reduction to service-fee and commission revenue. The company also recognized additional amortization from acquired intangible assets.
- Management described COVID-19 effects as uncertain: vehicle supply shortages and increased used-car demand affected warranty businesses, with positive and negative revenue effects; earlier declines in home sales reduced new-home warranty enrollments. Further disruption, investment losses, impairment or covenant effects remained possible.
- Debt, liquidity and capital constraints are prominent risks. Variable-rate subordinated and acquisition debt expose the company to interest-rate increases; management estimated each 100-basis-point increase in LIBOR or its replacement benchmark could raise annual interest expense by about $1.4 million. LIBOR transition arrangements and restrictive debt covenants are additional considerations.
- Class A preferred shares with a $6.5 million redemption value were not redeemed on the April 2021 redemption date because the company lacked sufficient legally available funds and was prohibited from redeeming shares while trust-preferred interest was deferred. The shares remain convertible and continue to accrue dividends.
- Material contingencies include the Aegis settlement, requiring reimbursement of 60% of certain future losses up to $4.8 million, and the Mendota sale indemnity, capped at $2.5 million. The company reported no liability for these exposures because amounts were not reasonably determinable. Ordinary-course litigation also remains possible.
- A single BNSF Railway lease customer generated more than 10% of consolidated revenue. Tenant performance and long-term lease economics are material risks. Amigo, the insurance subsidiary in voluntary run-off, exceeded the 200% RBC threshold; its reported RBC was 8,417% at year-end.
- Management concluded disclosure controls and internal control over financial reporting were ineffective at December 31, 2021 due to one unremediated material weakness concerning accounting for and disclosure of complex, nonrecurring transactions, particularly ASC 606. Remediation was ongoing. The auditor issued an unqualified opinion on the financial statements but was not engaged to audit internal controls.
- The filing provides no quantified earnings or revenue guidance. Management’s stated 12-month liquidity expectation is subject to risks, including COVID-19 effects. The company has not declared a common dividend since 2009.
Important facts for investors to verify
- How much cash is unrestricted and available at the holding company, and whether expected subsidiary distributions comply with debt covenants.
- Debt balances, maturities, variable-rate exposure, LIBOR replacement terms, deferred trust-preferred interest and the preferred shares’ redemption and conversion status.
- Whether the reported tax benefit and improved consolidated net income are repeatable, given the continuing common-shareholder loss and valuation allowance against deferred tax assets.
- Performance and final purchase accounting for Ravix, including contingent consideration; and the operating contribution and financing of RoeCo.
- Progress in remediating the ASC 606 material weakness and any effects on revenue recognition or future financial reporting.
- Developments in Aegis and Mendota claims, the CMC settlement cash flows, and tenant and lease concentration risks.
- Whether COVID-related market conditions, warranty claims, investment valuations or debt covenants materially change from management’s year-end assumptions.